Infectious Disease In Vitro Diagnostics Market 2026 Advancing Rapid Detection And Public Health Preparedness

infectious disease in vitro diagnostics industry outlook

The Business Research Company's Infectious Disease In Vitro Diagnostics Market 2026 Advancing Rapid Detection And Public Health Preparedness

Expected to grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%”

— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, March 12, 2026 /EINPresswire.com/ -- "The infectious disease in vitro diagnostics market is dominated by a combination of global diagnostics leaders and specialized molecular testing companies that focus on advanced PCR platforms, rapid antigen and antibody assays, next-generation sequencing technologies, and integrated point-of-care diagnostic solutions to strengthen market presence and enhance clinical decision-making. Companies are emphasizing high-throughput automation, multiplex testing capabilities, digital connectivity, and laboratory information system integration to improve accuracy, turnaround time, and disease surveillance efficiency. Strong regulatory compliance, quality assurance standards, and continuous innovation in assay sensitivity and specificity remain central to competitive positioning. Understanding the competitive landscape is essential for stakeholders seeking growth opportunities, technological advancement, and strategic collaborations within the rapidly evolving clinical diagnostics and public health ecosystem.

Which Market Player Is Leading the Infectious Disease In Vitro Diagnostics Market?
• According to our research, F. Hoffmann-La Roche AG led global sales in 2024 with a 6% market share. The diagnostics division of the company, which is directly involved in the infectious disease in vitro diagnostics market, offers a comprehensive portfolio of molecular diagnostics, immunoassays, clinical chemistry platforms, and automated laboratory systems that support early detection, disease monitoring, and high-throughput testing for a broad range of infectious pathogens across hospital, reference laboratory, and point-of-care settings.

Who Are The Major Players In The Infectious Disease In Vitro Diagnostics Market?
Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., Merck KGaA, DiaSorin S.p.A., Meridian Bioscience, Inc., Quidel Corporation, Quest Diagnostics Incorporated, Revvity, Inc., OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories Ltd., Luminex Corporation, FUJIFILM Wako Pure Chemical Corporation, Bio-Rad Laboratories, Inc., Trivitron Healthcare Pvt. Ltd., InBios International, Inc.

How Concentrated Is The Infectious Disease In Vitro Diagnostics Market?
The market is moderately fragmented, with the top 10 players accounting for 23% of total market revenue in 2024. This level of concentration reflects significant technological complexity and stringent regulatory requirements, driven by rigorous clinical validation standards, compliance with global health authority guidelines, high R&D investments in molecular and immunodiagnostic platforms, and the need for accuracy, scalability, and rapid turnaround in infectious disease detection across diverse healthcare settings. Leading players such as F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc, hold notable market shares through diversified infectious disease assay portfolios, strong molecular diagnostics capabilities, established hospital and reference laboratory partnerships, global distribution networks, and continuous innovation in automated, high-throughput, and point-of-care diagnostic solutions. As demand for rapid pathogen detection, outbreak surveillance, decentralized testing, and integrated digital laboratory workflows grows, strategic collaborations, product innovation, and geographic expansion are expected to strengthen the competitive positioning of these leading companies in the market.

• Leading companies include:
o F. Hoffmann-La Roche AG (6%)
o Abbott Laboratories (3%)
o Danaher Corporation (3%)
o Thermo Fisher Scientific Inc. (3%)
o Siemens Healthcare AG (2%)
o bioMérieux SA (2%)
o QIAGEN N.V. (1%)
o Becton, Dickinson and Company (1%)
o Hologic, Inc. (1%)
o Labcorp Holdings Inc. (1%)

Request A Free Sample Of The Infectious Disease In Vitro Diagnostics Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=30303&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Mar_PR

Who Are The Key Raw Material Suppliers In The Infectious Disease In Vitro Diagnostics Market?
• Major raw materials suppliers in the infectious disease in vitro diagnostics market include Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Sartorius AG, Agilent Technologies, Inc., QIAGEN N.V., Revvity, Inc., Promega Corporation, Corning Incorporated, Greiner Bio-One International GmbH, Eppendorf SE, Takara Bio Inc., Kanto Chemical Co., Ltd., HORIBA, Ltd., Asahi Kasei Corporation, Shimadzu Corporation, R-Biopharm AG, and MBL Co., Ltd.

Who Are The Major Wholesalers And Distributors In The Infectious Disease In Vitro Diagnostics Market?
• Major wholesalers or distributors in the infectious disease in vitro diagnostics market include Cardinal Health, Inc., McKesson Corporation, Henry Schein, Inc., Owens & Minor, Inc., Medline Industries, LP, Concordance Healthcare Solutions, LLC, Premier, Inc., Patterson Companies, Inc., The Claflin Company, Vyttra Diagnósticos S.A., InGen, DKSH Holding Ltd., PHOENIX Group, Bunzl plc, Morris & Dickson Co., LLC, Bimedis.

Who Are The Major End Users Of The Infectious Disease In Vitro Diagnostics Market?
• Major end users in the infectious disease in vitro diagnostics market include Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Scientific SE, Mayo Clinic Laboratories, ARUP Laboratories, Cleveland Clinic, Johns Hopkins Medicine, Kaiser Permanente, Apollo Hospitals Enterprise Ltd., Fresenius Medical Care AG & Co. KGaA, Bupa, Sonic Healthcare Limited, SYNLAB AG.

What Are the Major Competitive Trends In The Market?
• Clinical Diagnostics And Public Health Surveillance Tools are transforming the infectious disease in vitro diagnostics market by enhancing early disease detection, strengthening outbreak preparedness, and enabling real-time epidemiological data analytics across healthcare and community settings.
• Example: In April 2025, bioMérieux SA launched Watchfire, a molecular testing solution targeting viruses and bacteria in wastewater for population-level monitoring.
• Running on the BIOFIRE FilmArray Torch System and integrated with FIREWORKS software, it delivers real-time trend analysis and early warning alerts, enabling proactive outbreak detection, supporting antimicrobial resistance surveillance, and strengthening informed public health decision-making.

Which Strategies Are Companies Adopting To Stay Ahead?
• Developing Rapid Multi-Pathogen Detection Solutions To Enhance Timely Diagnosis
• Advancing Rapid Multi-Target Detection Solutions For Avian Influenza A H5 Virus To Strengthen Early Diagnosis
• Developing Fully Automated PCR Testing Solutions With Real-Time Data Analytics To Enhance High-Throughput Pathogen Detection, And Disease Surveillance
• Innovating Integrated Antibiotic Susceptibility Testing Systems To Improve Diagnostic Accuracy

Access The Detailed Infectious Disease In Vitro Diagnostics Market Report Here
https://www.thebusinessresearchcompany.com/report/global-infectious-disease-in-vitro-diagnostics-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Mar_PR

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 17,500 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.

Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.

Contact Us:
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: info@tbrc.info

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.